Archive for the ‘North Atlantic Treaty Organization’ Category
Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians
ROCKVILLE, Md., Jul 12, 2010 (BUSINESS WIRE) –
Emergent BioSolutions Inc. (NYSE:EBS) is hosting “Bioterrorism Prevention, Preparedness and Response,” a forum organized for members of the North Atlantic Treaty Organization (NATO) Parliamentary Assembly (PA) to raise global awareness of the importance of biopreparedness. The visiting delegation [...]
July 13, 2010
Tags: Anthrax vaccines, Emergent BioSolutions, Food and Drug Administration, NATO, United States Department of Health and Human Services, United States. Posted in: Emergent BioSolutions, NATO, North Atlantic Treaty Organization, United States Department of Health and Human Services, Vaccine. 
No Comments
Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly
Emergent BioSolutions’ senior management team, headed by Fuad El-Hibri, chairman and chief executive officer and Daniel J. Abdun-Nabi, president and chief operating officer, are hosting “Bioterrorism Prevention, Preparedness and Response,” a forum uniquely organized for members of the North Atlantic Treaty Organization (NATO) Parliamentary Assembly (PA). The one-day event is an interactive discussion related to [...]
May 11, 2010
Tags: Chief executive officer, Emergent BioSolutions, fuad el-hibri, Hudson Institute, NATO, North Atlantic Treaty Organization, United States Department of Defense, United States. Posted in: Emergent BioSolutions, Hudson Institute, North Atlantic Treaty Organization, United States Department of Defense, fuad el-hibri No Comments